Doctors not mandated to inform patients on drug side effects: Delhi HC

Delhi High Court dismissed a public interest litigation that sought to enforce the compulsory disclosure of drug side effects by doctors to the patients

pharmaceutical sector, pharma sector, medicines, meds
Photo: Bloomberg
Vasudha Mukherjee New Delhi
2 min read Last Updated : May 20 2024 | 6:16 PM IST
The Delhi High Court recently dismissed a public interest litigation (PIL) petition seeking directions for medical professionals to specify in writing all possible risks and side effects associated with pharmaceutical drugs prescribed to patients, according to a report by Bar and Bench.

The PIL, filed by Jacob Vadakkanchery, argued that patients have the right to an informed choice regarding their treatment. Thus, it should be mandatory for doctors to explain the side effects of any prescribed medication. Vadakkanchery contended that failing to inform patients of potential side effects compromises the validity of their consent.

A Division Bench of Acting Chief Justice Manmohan and Justice Manmeet Pritam Singh Arora considered the petition. The Bench said the existing legal framework already addresses the issue. According to the Drugs and Cosmetics Act, 1945, drug manufacturers or their agents are required to provide a package insert disclosing the side effects of drugs. Additionally, the Pharmacy Practice Regulations, 2015 stipulate that registered pharmacists inform patients about possible side effects of medications.

The Bench said that since the legislature has placed the duty of informing patients about drug side effects on manufacturers and pharmacists, there is no need for the court to issue further directions. The court reasoned that doing so would amount to judicial legislation, which is not within its purview.

The Bench noted that imposing additional duties on doctors through judicial directions would constitute judicial legislation, which is beyond the court’s jurisdiction.

It also observed that the petitioner did not dispute the adequacy of information provided by manufacturers and pharmacists through package inserts.

The court found no grounds to issue the directions sought in the PIL, as it would overlap with the legislature’s domain. The PIL, along with the applications, was dismissed, with the court stating, “Since, in the present PIL it is admitted that there is no vacuum, the directions prayed for cannot be issued.”
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :doctors in IndiamedicineMedicinesMedicines in Indiapharmacypharmaceutical firmsDelhi High Court

First Published: May 20 2024 | 6:16 PM IST

Next Story